ArticleDrug design, development and therapy2026

The Efficacy and Safety of Telitacicept versus the Recommended Regimens in IgA Nephropathy: A Single-Center Experience.

Xueting Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.